Results
1 -
10 of
33Matrix Metalloproteinase Inhibitors: Applications in Oncology, Investigational New Drugs Matrix metalloproteinase inhibitors, Prognostic variables in node-negative and node-positive breast cancer Hydroxyurea and hydroxamic acid derivatives as antitumor drugs, Cancer Chemotherapy and Pharmacology Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials, Cancer and Metastasis Reviews Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor, Clinical & Experimental Metastasis Matrix Metalloproteinase Expression in Lung Cancer, Lung Cancer Cancer Drug Discovery and Development, Chemoradiation in Cancer Therapy Matrix metalloproteinase inhibitors, Current Oncology Reports Matrix Metalloproteinase Inhibitors for Cancer Therapy, Pharmaceutical Innovation